Athena Investment Management’s AbbVie ABBV Stock Holding History

Athena Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.47M	Hold	11,340	–	–	1.28%	12
2025 Q4	$2.59M	Sell	11,340 -9	-0.1%	-$2.05K	1.33%	10
2025 Q3	$2.63M	Sell	11,349 -12	-0.1%	-$2.44K	1.37%	9
2025 Q2	$2.11M	Sell	11,361 -25	-0.2%	-$4.65K	1.18%	14
2025 Q1	$2.39M	Hold	11,386	–	–	1.44%	10
2024 Q4	$2.02M	Sell	11,386 -3	-0%	-$552	1.17%	13
2024 Q3	$2.25M	Sell	11,389 -8	-0.1%	-$1.49K	1.28%	11
2024 Q2	$1.95M	Sell	11,397 -30	-0.3%	-$4.97K	1.19%	13
2024 Q1	$2.08M	Sell	11,427 -3	-0%	-$517	1.25%	12
2023 Q4	$1.77M	Sell	11,430 -3	-0%	-$437	1.15%	14
2023 Q3	$1.7M	Sell	11,433 -20	-0.2%	-$2.94K	1.22%	13
2023 Q2	$1.54M	Sell	11,453 -31	-0.3%	-$4.55K	1.06%	16
2023 Q1	$1.83M	Hold	11,484	–	–	1.32%	13
2022 Q4	$1.86M	Buy	11,484 +39	+0.3%	+$5.98K	1.36%	12
2022 Q3	$1.54M	Hold	11,445	–	–	1.29%	14
2022 Q2	$1.75M	Buy	11,445 +159	+1%	+$24.3K	1.38%	12
2022 Q1	$1.83M	Buy	+11,286	New	+$1.64M	1.42%	12

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Athena Investment Management's ABBV Position: Q1 2026 in Review

Athena Investment Management held its AbbVie (ABBV) position steady in Q1 2026 at 11,340 shares worth $2.47M. The position accounts for 1.28% of the portfolio, ranked #12.

Athena Investment Management first reported a position in ABBV in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.63M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Athena Investment Management held 11,340 shares of AbbVie worth $2.47M as of Q1 2026.
Athena Investment Management left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 1.28% of Athena Investment Management's portfolio in Q1 2026, its #12 holding.
Athena Investment Management first reported a position in AbbVie in Q1 2022 and has held it in 17 quarters since.
Athena Investment Management's AbbVie position peaked at $2.63M in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Athena Investment Management's 13F filing for Q1 2026, filed 12 May 2026.